The participants of Boston’s Men’s March to Abolish Abortion and Rally for Personhood had only made it a few steps down ...
With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
Zacks.com on MSN20h
Boston Scientific Stock Set to Gain From Completion of Axonics DealBoston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...
20h
In a report released on November 15, David Rescott from Robert W. Baird maintained a Buy rating on Boston Scientific (BSX – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback